The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.
作者信息
Eapen Mathew Suji, Gaikwad Archana Vijay, Thompson Isobel E, Lu Wenying, Myers Stephen, Sharma Pawan, Sohal Sukhwinder Singh
机构信息
Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, Tasmania, Australia.
Medical Sciences, University of Technology Sydney, Sydney, NSW, Australia.
出版信息
J Thorac Dis. 2019 May;11(Suppl 9):S1139-S1142. doi: 10.21037/jtd.2019.04.44.
Abstract
摘要
相似文献
1
The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.免疫抑制药物环孢素在减缓间质性肺病进展方面的有效性。
J Thorac Dis. 2019 May;11(Suppl 9):S1139-S1142. doi: 10.21037/jtd.2019.04.44.
2
[Cyclosporin treatment of interstitial pneumonia and monitoring of serum concentration].
Nihon Kokyuki Gakkai Zasshi. 2004 Nov;42(11):934-40.
3
[Successful therapy of cyclosporin A in a case with idiopathic interstitial pneumonia].[环孢素A成功治疗一例特发性间质性肺炎]
Arerugi. 2001 Apr;50(4):399-406.
4
Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
J Heart Transplant. 1988 Mar-Apr;7(2):111-7.
5
[Cyclosporin and diffuse alveolar interstitial lung disease].[环孢素与弥漫性肺泡间质肺疾病]
Arch Bronconeumol. 1996 Jun-Jul;32(6):302-6.
6
Progression of fibrosis in usual interstitial pneumonia: serial evaluation of the native lung after single lung transplantation.寻常型间质性肺炎中纤维化的进展：单肺移植后对自体肺的系列评估
Respiration. 2008;76(2):139-45. doi: 10.1159/000108440. Epub 2007 Sep 13.
7
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.他克莫司与环孢素作为肺移植受者的初始免疫抑制治疗比较
Cochrane Database Syst Rev. 2013 May 31(5):CD008817. doi: 10.1002/14651858.CD008817.pub2.
8
Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.自身免疫性肺泡蛋白沉积症在多发性肌炎伴间质性肺病的免疫抑制治疗中发生：一例报告。
BMC Pulm Med. 2020 Apr 6;20(1):84. doi: 10.1186/s12890-020-1110-5.
9
Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease.两例皮肌炎合并间质性肺病患者在免疫抑制治疗期间发生自身免疫性和继发性肺泡蛋白沉积症。
Mod Rheumatol. 2018 Jul;28(4):724-729. doi: 10.3109/14397595.2016.1153443. Epub 2016 Mar 11.
10
Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.环孢素作为病因不明的间质性肺病的一种治疗方法。
Thorax. 1991 Aug;46(8):592-5. doi: 10.1136/thx.46.8.592.
引用本文的文献
1
The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies.巨噬细胞在结缔组织病相关间质性肺疾病中的作用：聚焦于分子机制和潜在治疗策略。
Int J Mol Sci. 2023 Jul 26;24(15):11995. doi: 10.3390/ijms241511995.
2
Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition.特发性肺纤维化患者的血管重塑及其对肺生理的有害影响：内皮-间充质转化的潜在作用
ERJ Open Res. 2022 Mar 21;8(1). doi: 10.1183/23120541.00571-2021. eCollection 2022 Jan.
3
Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections.血管紧张素转换酶2（ACE2）、跨膜丝氨酸蛋白酶2（TMPRSS2）和弗林蛋白酶在特发性肺纤维化（IPF）和淋巴管平滑肌瘤病（LAM）患者肺中的表达增加：对严重急性呼吸综合征冠状病毒2（SARS-CoV-2，即新冠病毒）感染的影响。
J Clin Med. 2022 Jan 31;11(3):777. doi: 10.3390/jcm11030777.
本文引用的文献
1
Cyclosporin A in idiopathic chronic fibrosing interstitial pneumonia without idiopathic pulmonary fibrosis.环孢素A用于无特发性肺纤维化的特发性慢性纤维化间质性肺炎
J Thorac Dis. 2018 Dec;10(12):6695-6701. doi: 10.21037/jtd.2018.11.70.
2
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.进行性纤维性间质性肺疾病谱的表现、诊断和临床过程。
Eur Respir Rev. 2018 Dec 21;27(150). doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31.
3
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.进展性肺纤维化性间质性肺疾病的药物治疗管理：当前证据综述。
Eur Respir Rev. 2018 Dec 21;27(150). doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31.
4
Role of imaging in progressive-fibrosing interstitial lung diseases.影像学在进行性纤维性间质性肺疾病中的作用。
Eur Respir Rev. 2018 Dec 21;27(150). doi: 10.1183/16000617.0073-2018. Print 2018 Dec 31.
5
Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors.特发性肺纤维化：揭开特发性环境因素的面纱。
Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01699-2018. Print 2019 Feb.
6
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
7
Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.具有自身免疫特征的间质性肺炎在慢性纤维性间质性肺炎患者中的特征和预后意义。
Respir Med. 2018 Apr;137:167-175. doi: 10.1016/j.rmed.2018.02.024. Epub 2018 Mar 1.
8
Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: implications for new therapeutic targets.了解慢性肺部疾病中微生物发病机制的新机制：对新治疗靶点的启示。
Clin Sci (Lond). 2018 Feb 8;132(3):375-379. doi: 10.1042/CS20171261. Print 2018 Feb 14.
9
Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD).在吸烟者和慢性阻塞性肺疾病（COPD）患者的小气道壁和管腔中，存在异常的 M1/M2 巨噬细胞表型谱。
Sci Rep. 2017 Oct 17;7(1):13392. doi: 10.1038/s41598-017-13888-x.
10
Potential Mechanisms of Microbial Pathogens in Idiopathic Interstitial Lung Disease.
Chest. 2017 Oct;152(4):899-900. doi: 10.1016/j.chest.2017.05.024.
Zotero 插件